Transcripts For RT Boom Bust 20240711 : comparemela.com

Transcripts For RT Boom Bust 20240711

Up are you leadership all of us sit down with one of us russia but next 5 back to the producers for an exclusive look into the shot of russia plans to vaccinate general public and soon as next week the 1st country to authorize emergency use of fighter and by a government. Of britain is also looking for roll out that are seen as really. Have a lot to get through so lets get started. As the world moves closer to mass vaccinations against covert 19 russia was one of the 1st countries to register its sputnik 5 vaccine several nations have raised questions regarding the back seems africa c citing a lack of data according to a press release from the countrys coronavirus headquarters russian president Vladimir Putin announced his plans to begin a large scale vaccinations as early as next week with millions of doses already produced in the country your leadership of all of us sits down for an exclusive interview with the c. E. O. Of one of the companies tapped to mass produce the sputnik 5. Models dimitri models of c. E. O. Of bio cad one of the companies expected to launch production of the coated 19 back scene is that correct you just would think you are very clear already manufacturing the vaccine are the only question. It is the volume and the time it will take to complete the order lets be more specific that which vaccine are we talking about we know that there are currently 3 different Vaccines Available on the russian market which if. I am of course talking about sputnik 5 developed by the gov Research Institute at the moment the vaccine is undergoing Clinical Trials but it has already been registered and is being produced to vaccinate specific population groups which you have a contract with the government to produce that axiom correct. Its all very simple really we serve as a platform for the contract but the whole process is put together and managed by the gumbel a Research Institute in collaboration with the Health Ministry our role is to fulfill the contract by producing the required number of doses in the established timeframe and in school you can how many doses do we need. That is determined by the Health Ministry i know our colleagues there have developed a detailed vaccination schedule and you have the capacity to complete the order. Certainly as part of a Larger Mission we have specific objectives and target volumes to reach and not just us our Companies Carry their share of the load. We know that for russians the vaccine will be free and the vaccination voluntary compared to other vaccines including foreign ones is the cost of production higher or lower. Im not authorized to disclose the pricing details at this moment but i can assure you that its very affordable also you already mentioned the entire program is state funded im sure that this vaccine will not be distributed via commercial channels at least for now. What about potential orders from foreign countries. The Russian Direct Investment Fund is actively working on this. You must have heard the c. E. O. Curly read 3 of speaking about this i talked to him yesterday they are now discussing the possibility of exploiting the vaccine abroad its been reported that vaccine production will be launched in india as well. For the move and youve got to know who i can confirm that there is a cooperation project to this end underway with a partner from india and another partner from argentina and were also on track for similar cooperation with south korea we all know that other countries are developing covert 19 vaccines as well including the u. S. And the u. K. We have also heard reports in the media about the russian back scenes being 92 percent effective it was the most interesting thing here however is that we are in fact talking about 2 vaccines the vaccine developed by the common law Research Institute consists of 2 different shots its a quite complex task in terms of production because you have to manufacture 2 vaccines as opposed to one ok then what if other manufacturers produce a simpler vaccine one that requires only one shot would it be a short cut to the same goal. But then you will see the effectiveness of the short cuts once the Clinical Trials are completed but also time will tell which vaccine is more efficient and provides better immunity in the long term western experts say that we russians are rushing into this because any vaccine needs to be tried and tested for a fairly long period of time and weve done everything so fast its obvious of course that we cant drag our feet here because we need this now. What our western counterparts make statements we need to look very closely at who does it and what theyre saying exactly for example they frequently complain that the got away institute hasnt published enough data and so on when you question the station i mean. Personally i think there isnt enough information on either russian made vaccines or the back. Scenes that are being developed in other countries in terms of their safety how can you prove that theyre safe how are you going to convince people to vaccinate thats a very important issue another question is what is the human adenovirus where are you going to get it to make the vaccine by this point weve seen convincing data that proves the vaccine is safe it was proven during preclinical animal testing im talking about safety now not effectiveness that it was proven during Clinical Trials on Healthy Volunteers weve done all bad statistics show that the vaccine is safe you also asked where we would get the adenovirus thats part of our job of course and the job of the researchers who develop this vaccine there are special cell banks for that. Will the backseat effectiveness and very depending on the age group will only be able to tell after the trials are over and who the right no additional Clinical Trials are taking place for people age 60 plus some data will be published in the near future as to what extent this but nik by vaccine should be administered to older people well but also in the log book on the edge of a financial question as we know that production has a financial aspect to it and is linked to a lot of risks in case some trials are wiil that the vaccine is not as effective as we had hoped wouldnt it make sense to 1st produce a smaller batch rather than go into large numbers right away weve been watching our western colleagues who have encountered a number of negative side effects during their trials and we saw that those experts suspended their trials and studied the causes of those negative side effects then based on this research they make special risk profiles explaining which patient should take the vaccine and which should so the groups of people to be inoculated 1st are determined according to this risk profile and the Research Data thats available do you believe in the spotlight back saying i do ive had my shots already and your family my family to both my wife and myself. My children though as there is no reason vaccinate them i got it when the very 1st Clinical Trial started and my wife a bit later so our country has enough Production Capacity to complete the state contract which would be how many doses this is determined by our Health Ministry based on our epidemiological model but you must know the numbers at least for the early stage i have signed the name so i cannot disclose anything but i am positive that our Production Capacity will be enough to handle it. The United Kingdom is the 1st in the world to formally approve the pfizer and biotech over 1000 vaccine prize or c. E. O. Called it a historic moment on wednesday the u. K. s medicines and Health Care Products Regulatory Agency granted emergency approval for the vaccine which they say is 95 percent effective in preventing severe illness biotech chief medical officer said it already began the process of delivering the drug to the u. K. We have started immediately the process of delivering our vaccine with delivering a lot of axion and we expect that for all our to offer vaccine in the u. K. Will happen with next couple of days. British leaders the elderly will have priority followed by front line workers and social workers both the u. S. And the European Union regulators are going over some of the data but they have not yet decided on whether to approve the vaccine for more were joined by the total time investigative journalist been swan and board member of the British American Business Association hillary for which hillary good to see you hilary lets start with you how big of a deal is this for the u. K. To begin the distribution of pfizers vaccine well sarah pleasure to be back with you and in short its a big deal 2 aspects of this though and 1st of all the deployment and then what this means is of the e. U. In terms of the deployment Simon Stephens the c. E. O. Of the n. H. S. Yes thats the National Health service has said yes the deployment is ready for next week and it will 1st go as you mentioned to me and to the Frontline Health care workers so thats going to be staggered throughout the u. K. There is enough in the u. K. Currently since this is a dose vaccine for vaccinations to a car for about a 3rd of the population 66000000 people so a 3rd of 66000000 people will get these vaccinations and it will start quickly i think the one point is that of course the u. K. With the n. H. S. Has a very centralized system the caution then is though by jonathan hes the deputy medical minister for the u. K. As he said you know this vaccinate vaccine is not like your gut it has to be stored at minus 70 degrees and you can take it in and out of refrigeration like you can and youre good and open it and close it and put the lid back on and put it back in the refrigerator so there are also logistical concerns as to how this will be deployed but nevertheless the n. H. S. Is centralized and i think youll see this rollout fost quickly next week rather fast and it will be efficient and and well done this is in contrast of course and this brings us to an issue we discuss a lot is in contrast to the e. U. The german minister peter lysol has said that he doesnt see why the u. K. Is rushing into this and that the the committees have to be far more. And so the e. U. Is going to be reviewing this and the results should come out december 29th and then obviously thats the Pfizer Vaccine and the madonna vaccine on january 12th so all projections all at least it will be about a month later in the e. U. At the earliest so to answer your question and not show a big deal sara that the e. U. Has moved so quickly a big deal especially for the u. K. Who has struggled to contain the virus in the 1st place and life not without facing some issues as far as administration how they plan to administer the vaccine exactly and we may see even more problems doesnt look like its going to be as easy as as they claim or say theyre trying to make it but then both pfizer and major know that theyre seeking emergency f. D. A. Approval here in the United States as well but both companies are also seeking that approval in europe at the same time right. Yeah they are and i hillary covered a lot of that so let me just say this about both modern and both pfizer and by the way fantastic interview to lead off the show with theres a lot of information there about this but the vaccine and what that ultimately means as well but it really comes down to 2 major issues with the vaccine number one is as hillary was talking about storage of those vaccine units so in the u. K. In europe in the United States there are Big Questions about that theres also Big Questions about who gets the vaccines 1st and of course the question of how long will it last we dont know the answers to the questions about the actual efficacy in terms of long term protection for any of these these vaccines because theyre so new and there hasnt been enough Research Done number one number 2 its also important to remember that there are indications that these vaccines may not prevent someone from spreading the virus so it may prevent you from getting sick but it may not prevent you from spreading it so there are a lot of questions about that as well and then thirdly theres the the issue of who gets it obviously theres a lot of talk about it going to frontline workers Health Care Workers and the elderly 1st but its interesting what was said in that interview with the russian scientist where he mentioned that in russia you know his wife has taken it hes taken it but his children will not because children dont need the vaccine Dr Anthony Fauci just said the same thing very similarly here in the United States recently not about the vaccine but about the fact that kids dont really get sick from this he said it over the weekend and that kids are the least at risk so the question is will the u. S. And europe treat their vaccines the same way that the russians are in terms of not necessarily giving it to children i doubt that will be the case but its in that an interesting contrast in terms of kind of the political dynamic a lot of the country just wants to get back to normal theyre looking for the quick the quick aid a cure for this right the vaccine something that we havent seen yet is at least to this point is how quickly its a vaccine was developed this new technology m r n a the fact that the efficacy is so high that a lot of people trust but a lot of people still do not trust are we supposed to try to be back to normal though only if we reach some sort of herd immunity. Well thats true but think about what youre saying in terms of the efficacy rates the efficacy rates at 9294. 5 and 95 percent the flu vaccine that we have in this country that we use there obviously we have different versions of it the highest because if weve ever had for a flu vaccine is 60 percent the lowest is 10 percent so when youre talking about now youve rushed into development these vaccines that suddenly have the highest because the rates in the world in terms of of treating a virus like this and they were the fastest produced you have to kind of step back and say those numbers are accurate because again those are numbers that are coming in the form of press releases from Big Pharma Companies they have not been verified well will see about that especially we dont know about the long term side effects tell you one more question before we run out of time we do want to touch on braggs that we have less than 30 days to go and it looks like we could be looking at a no deal brags that with europe what are the Sticking Points here give us a few Sticking Points i just want to add one thing to what bens that very thoroughly covered that he did one thing that nobody even talks about birth defects that how can they study their longevity the long long term effects of this and the longevity in terms of birth defects for the next gen im not sure today we have pregnant women are even going to be want to go and get that out of what about my sons of what about my grandchildren you know would they get a positive anyway thats a whole nother issue but you asked about rex said yes im getting really close now down to the wire i thought it was very interesting that mccrone recently met with the belgian Prime Minister and he actually said that he is that hes afraid that this is going to be a football analogy that britain is going to have a loss a goal in the last minute i think a couple of things that happened the u. K. Actually has conceded a little bit in terms of the fishing rights theyve gone from requesting and demanding that 80 percent of all fish caught in their waters over time and that its only 60 percent so i think the u. K. Has negotiated in good faith but its actually coming out that the european leaders are particularly concerned because they feel that bania is likely to concede because he wants to get this done and vandelay also what she wants to do is have on her legacy of course that theres been some concession. I think the biggest Sticking Point actually is a mess because of his fishing villages and fishing towns around the English Channel and the amount of fish is the discord in the british war waters Boris Johnson is Holding Steady saying that these are all sovereign waters and we want sovereignty back so the remaining sticking issue of course of fisheries but also governance the one thing also the u. K. Has conceded on is also with regard to human rights and i think thats totally fine because you know human rights across a level Playing Field across europe they should be the same standards cohost investigative journalist. And board member British American Business Association hurry forward to tell the time how for today but thank you so much for joining and this great discussion. But when we come back European Union and the asian group have agreed to form a Strategic Partnership explain what this means for more than a 1000000000 people that

© 2025 Vimarsana